ZJYLHealthcare · Medical Instruments & SuppliesTicker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 14 of 100 as at 12 Oct 2026 — in the weakest quartile.
Consensus tells you what everyone already believes. The model scores Jin Medical International Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (58): Smaller than most of the companies we track.
Volatility (8): The share price moves around a lot.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on ZJYL, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ZJYL appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 12 Oct 2026, Jin Medical International Ltd. returned −73.9% against +20.4% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 52% of US stocks
Cheaper than 16% of US stocks
Cheaper than 82% of US stocks
Cheaper than 1% of US stocks
Higher than 16% of US stocks
Higher than 15% of US stocks
Higher than 25% of US stocks
Higher than 62% of US stocks
Higher than 52% of US stocks
Higher than 46% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Jin Medical International Ltd. has a market value of $164.3M and an enterprise value of $163.2M.
Trailing P/E: 12.2×.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Jin Medical International Ltd. employs 273 people.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Jin Medical International Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Jin Medical International Ltd. reported its unaudited financial results for the six months ended March 31, 2026, covering the first half of fiscal year 2026.
Why it matters — The announcement provides ZJYL watchers with the company's latest financial performance data and operational update for the first half of fiscal 2026.
As at 12 Oct 2026, Jin Medical International Ltd. ranks 14 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (58 of 100).
No analyst covering Jin Medical International Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ZJYL are extrapolating price history, which says nothing about the business.
Jin Medical International Ltd. returned -73.9% over the 12 months to 12 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Jin Medical International Ltd. Class A Ordinary Shares represents equity in Jin Medical International Ltd., a healthcare equipment company focused on rehabilitation medical products and mobility support solutions.
The most recent item we track (PRNewsWire, 4 Aug 2026): "JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results". Jin Medical International Ltd. reported its unaudited financial results for the six months ended March 31, 2026, covering the first half of fiscal year 2026.
Jin Medical International Ltd. Class A Ordinary Shares represents equity in Jin Medical International Ltd., a healthcare equipment company focused on rehabilitation medical products and mobility support solutions. The company designs, develops, manufactures, and sells wheelchairs, rehabilitation medical equipment, and living aids used by people with disabilities, older adults, and individuals recovering from injury. Its product range also includes related medical and daily-living assistance devices, supporting use in home care, clinical settings, and rehabilitation environments. Jin Medical International Ltd. serves customers in China and international markets through its operating entities in the medical instruments and supplies segment. The Class A Ordinary Shares reflect the company’s ownership structure and are part of its dual-class share framework, which is used in corporate governance and shareholder rights.
CEO Mr. Erqi Wang · 273 employees · China · https://www.zhjmedical.com
